Characterizing Surveillance Recommendations From National Comprehensive Cancer Network Guidelines
Alison S. Baskin, Alina Keshwani, Manvir Bains, Christina Fleischer, Lesly A. Dossett
TL;DR
This study analyzes cancer surveillance guidelines to understand how specific and detailed the treatment recommendations are.
Contribution
The study provides a characterization of surveillance recommendations in cancer treatment guidelines.
Findings
The study identifies variations in the specificity of cancer surveillance recommendations.
It highlights differences in the length and detail of treatment recommendations across cancer types.
Abstract
This quality improvement study examines National Comprehensive Cancer Network clinical guidelines for cancer surveillance by type and characterizes specificity and length of recommended treatments.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGlobal Cancer Incidence and Screening · Clinical practice guidelines implementation · Economic and Financial Impacts of Cancer